DCOY
NASDAQ · Biotechnology
Decoy Therapeutics Inc
$0.78
+0.16 (+25.79%)
Income Statement
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.28M | 1.20M | 1.36M |
| Net Income | 141.5K | 105.1K | 144.5K |
| EPS | — | — | — |
| Profit Margin | 11.1% | 8.8% | 10.6% |
| Rev Growth | +11.3% | +13.4% | -9.5% |
Balance Sheet
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Total Debt | 437.0K | 457.4K | 468.9K |
| Total Equity | 1.41M | 1.62M | 1.55M |
| D/E Ratio | 0.31 | 0.28 | 0.30 |
Cash Flow
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| EBITDA | 291.4K | 241.4K | 275.9K |
| Free Cash Flow | 83.4K | 101.2K | 72.7K |